Search Within

Melica Nourmoussavi Brodeur

Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Department of Pathology and Laboratory Medicine (9)
  2. GDMT, Pathology and Laboratory Medicine (9)
  3. Gynecology Disease Management Team (9)
  4. Sloan Kettering Institute Postdocs (9)
  5. Department of Medicine (7)
  6. GDMT, Medicine (7)

More Groups

People
  1. Britta Weigelt (9)
  2. Hunter Green (7)
  3. Dmitriy Zamarin (5)
  4. Nadeem Abu-Rustum (5)
  5. Aaron Praiss (4)
  6. Ryan Kahn (4)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (2)
Publications
  1. Gynecologic Oncology (4)
  2. Cancer Research (1)
  3. International Journal of Gynecological Cancer (1)
  4. Molecular Oncology (1)
  5. Science Advances (1)
  6. iScience (1)
Publishers
  1. Elsevier Inc. (4)
  2. Amer Assoc Advancement Science (1)
  3. American Association for Cancer Research (1)
  4. Cell Press (1)
  5. FEBS Press (1)
  6. Lippincott Williams & Wilkins (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TROP2 expression and therapeutic targeting in uterine carcinosarcoma
    Journal Article

    Moufarrij, S.; Dopeso, H.; Brown, D. N.; Green, H.; Gill, K.; Tengelin, J.; Brodeur, M. N.; Zammarrelli, W. A. 3rd; Varice, N.; Wu, M.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Evolution of tumor stress response during cytoreductive surgery for ovarian cancer
    Journal Article

    Praiss, A. M.; Moukarzel, L. A.; Zhu, Y.; Longhini, A. L. F.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Ozsoy, M. A.; Hanlon, E.; more...
    iScience (2025)

    Fulltext@MSK | Save
  • Intraperitoneal therapy with engineered Newcastle disease virus encoding interleukin-12 in combination with PD-1 blockade for ovarian cancer
    Meeting Abstract

    Kahn, R.; Ozsoy, M. A.; Green, H.; Gill, K.; Praiss, A.; Pesci, G.; Burman, B.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity
    Journal Article

    Brodeur, M. N.; Dopeso, H.; Zhu, Y.; Longhini, A. L. F.; Gazzo, A.; Sun, S.; Koche, R. P.; Qu, R.; Rosenberg, L.; Hamard, P. J.; more...
    Science Advances (2024)

    Fulltext@MSK | Save
  • ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype
    Journal Article

    Brodeur, M. N.; Selenica, P.; Ma, W.; Moufarrij, S.; Dagher, C.; Basili, T.; Abu-Rustum, N. R.; Aghajanian, C.; Zhou, Q.; Iasonos, A.; more...
    Molecular Oncology (2024)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Surgical stress promotes IL-6-driven tumor progression in ovarian cancer
    Meeting Abstract

    Praiss, A.; Longhini, A. L. F.; Pesci, G.; Green, H.; Ozsoy, M.; Kahn, R.; Brodeur, M.; Bhaloo, S.; Merghoub, T.; Wolchok, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Exploiting SMARCA2 dependency for targeted therapy in SMARCA4-deficient ovarian cancers
    Meeting Abstract

    Brodeur, M.; Dopeso, H.; Green, H.; Ito, K.; Hulse, M.; Brown, J.; Weigelt, B.; Zamarin, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Endogenous retrotransposable elements induction in SMARCA4-deficient ovarian cancer is associated with immunomodulatory changes in the tumor microenvironment
    Meeting Abstract

    Brodeur, M. N.; Sun, S.; Zhu, Y.; Greenbaum, B.; Weigelt, B.; Zamarin, D.
    Cancer Research (2022)

    Fulltext@MSK | Save